Stock screener

IQV

Conviction 82HealthcareScan · Tue, Sep 8, 2026
Three inside down
IQV$259.20-3.20%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 1.39M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
IQVIA HOLDINGS INC.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.iqvia.com ↗
Price259.20
Change-3.20%
Gap-1.76%
Rel volume1.53×
Avg volume1.28M
Avg $ vol328.91M
SMA 20254.87
SMA 50231.49
SMA 200202.10
Price vs 50+11.97%
Price vs 200+28.26%
MA stackbullish
50/200 cross—
Supertrendup · 245.37
RSI (14)59
MACD hist-0.83
MACD crossbear · 4d
Stoch %K / %D60 / 82
ADX (14)39
+DI / −DI27 / 14
RSI divergence—
MACD divergence—
ATR %+2.98%
ADR %2.81%
52w high271.62
52w low156.66
From 52w high-4.57%
Above 52w low+65.45%
New 52w highNo
SqueezeOff
Bollinger width15.94%
%B0.61
Donchian pos66.88%
Donchian high271.80
Donchian low233.76
AVWAP (52w high)263.45
vs AVWAP high-1.61%
AVWAP (52w low)202.65
vs AVWAP low+27.91%
OBV trendFlat
Chaikin MF (20)0.26
Today vs 20d1.53×
Avg vol (14d)1.39M
Avg vol (20d)1.28M
Avg $ vol (20d)328.91M
Market cap43.26B
RS 3m (vs SPY)+41.54%
RS 6m (vs SPY)+38.91%
RS line new highNo
Trend template6/8
Technical rank86.2
1 week-0.76%
1 month+8.59%
3 months+41.11%
6 months+45.17%
1 year+38.11%
YTD+15.01%
P/E31.81
P/B6.95
P/S2.65
P/FCF21.09
EPS7.84
Div yield1.31%
ROE21.86%
ROA4.58%
Debt/Eq2.55
Current0.75
EV/EBITDA17.18
Gross margin—
Net margin8.34%
Rev growth5.87%
EPS growth-0.95%
Price target273.43
Target upside5.49%
Analyst ratingBuy
Institutional108.65%
Ent. value57.15B
Revenue4.15B
Net income274M
Gross profit915M
Free cash flow2.05B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNYSE
Shares out—
Employees93K
ListedThu, May 9, 2013
Free float160.54M
Float %94.6%
Short interest4.25M
Days to cover3.6d
Short volume58.5%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.75 vs $2.72
Last surprise+1.1% beat
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank86.2 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree inside down
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IQV · 7 recent

All disclosures →
MemberSideAmount
Markwayne Mullin
Markwayne Mullin
senate · traded 2025-12-29
Buy$15K–$50K
John Boozman
John Boozman
senate · R · AR · traded 2025-10-02
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Buy$15K–$50K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-02-25
Sell$1K–$15K
Markwayne Mullin
Markwayne Mullin
senate · traded 2025-02-13
Buy$15K–$50K
Markwayne Mullin
Markwayne Mullin
senate · traded 2024-08-20
Buy$15K–$50K

Insider activity

SEC Form 4 transactions in IQV · 10 buys

InsiderSideShares
DANHAKL JOHN G
Director · Deferred Shares · 2026-07-14
Grant160
Fasano Jim
Director · Deferred Shares · 2026-07-14
Grant195
GOGGINS COLLEEN A
Director · Deferred Shares · 2026-07-14
Grant183
Wims Morris Leslie
Director · Deferred Shares · 2026-07-14
Grant148
GOGGINS COLLEEN A
Director · Deferred Shares · 2026-05-07
Grant214
Fasano Jim
Director · Deferred Shares · 2026-05-07
Grant228
DANHAKL JOHN G
Director · Deferred Shares · 2026-05-07
Grant185
Wims Morris Leslie
Director · Deferred Shares · 2026-05-07
Grant171
GOGGINS COLLEEN A
Director · Common Stock · 2026-04-23
Grant1.57K
LEONARD JOHN M
Director · Common Stock · 2026-04-23
Grant1.57K

SEC filings

EDGAR filings in IQV · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.